DE1514719U - - Google Patents

Info

Publication number
DE1514719U
DE1514719U DENDAT1514719D DE1514719DU DE1514719U DE 1514719 U DE1514719 U DE 1514719U DE NDAT1514719 D DENDAT1514719 D DE NDAT1514719D DE 1514719D U DE1514719D U DE 1514719DU DE 1514719 U DE1514719 U DE 1514719U
Authority
DE
Germany
Prior art keywords
ttm
oia
mmm
öffnonpwhere
ßwffmt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1514719D
Other languages
German (de)
English (en)
Publication of DE1514719U publication Critical patent/DE1514719U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DENDAT1514719D Active DE1514719U (enrdf_load_stackoverflow)

Publications (1)

Publication Number Publication Date
DE1514719U true DE1514719U (enrdf_load_stackoverflow)

Family

ID=817077

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1514719D Active DE1514719U (enrdf_load_stackoverflow)

Country Status (1)

Country Link
DE (1) DE1514719U (enrdf_load_stackoverflow)

Similar Documents

Publication Publication Date Title
DE1514719U (enrdf_load_stackoverflow)
Bryson et al. Cladribine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies
Olliaro et al. Status of antimalarial drugs under development
Stickles et al. Atovaquone and ELQ-300 combination therapy as a novel dual-site cytochrome bc 1 inhibition strategy for malaria
Lemmermeyer Kuroda's class number formula
US10888558B2 (en) Regimens of tafenoquine for prevention of malaria in malaria-naive subjects
Fernández-Cruz et al. Zidovudine plus interferon-α versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts> 150x106/l: results of the Zidon trial
Fulco et al. Raltegravir-based HAART regimen in a patient with large B-cell lymphoma
Lake New prophylactic treatment strategy for cytomegalovirus disease
임원 et al. 0CgKK ggYYYmm mm
D'Amelio et al. Can the military contribute to global surveillance and control of infectious diseases?
Jensen et al. Aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a controlled, randomized trial
DE1428435U (enrdf_load_stackoverflow)
Muravyev et al. The limitations of proximate uniqueness: Evidence from Kazym Khanty
담없다 et al. SBS S kkS
KLMNO F@ R?@ SA'T U@ $ R'" U $@ GV'" V@ A@ U SAT" S $"'" &'!%'T WV!? $"# V#"# V'
Eenberg In modum dissertationis philosophicæ speude bradeōs levi penicillo perstrictum, consentiente ampliss. facult. philosoph. in regio athenæo Upsaliensi præside... mag. Johanne Eenberg... placido bonorum examini submittit s: æ r: æ m: tis alumnus Gustavus Joh. Herdman Dahlekarlus. Ad diem [8] Maji anni MDCCVI in audit. Gust. maj. horis solitis.
Reed Economic Packages for COVID-19 Recovery Must Invest in More Resilient Health Systems Cristian Morales MS MPH PAHO/WHO Permanent Representative, Mexico
Peters et al. The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate
Mierzwa et al. A Multiple Random Access Protocol for Bus Structured Local Area Networks Operating in Real-Time Environment
McIntosh Biological significance of discontinuous and scrambled ribosomal RNA genes in the mitochondria of malarial parasites
Cordova Optimal multicast trees to provide message ordering
Sulkowski et al. Clinical course of increased LFTs and hepatic events associated with ritonavir (RTV)-boosted tipranavir (TPV/r) based therapy in the RESIST trials
Prinsloo 'Geldwolfie'Interessante voorbeeld van samewerking
AshbyBuilding KarWeiShim, DermotJ. Monaghan, CecilG. Armstrong